← Issue №19/ week of Nov 8, 2026/IBD

The application of an artificial intelligence-enhanced virtual reality cognitive behavioral therapy tool is feasible and acceptable in patients with inflammatory bowel disease: A multicenter mixed methods pilot study.

From GI Signals issue №19: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

IBD prospective cohort · n=34 · Nov 5, 2026 · Inflamm Bowel Dis · IF 4.5

The application of an artificial intelligence-enhanced virtual reality cognitive behavioral therapy tool is feasible and acceptable in patients with inflammatory bowel disease: A multicenter mixed methods pilot study.

New evidenceartificial intelligencehealth services
Clinical takeawayNo clinical action yet: a pilot study showing feasibility and acute symptom reduction in a single session. Further trials are needed to assess sustained efficacy and integration into care.
What it foundA single AI-driven virtual reality CBT session reduced pain by 0.46 points (P=0.011) and anxiety by 10.65 points (P<0.001) immediately post-session in IBD patients.
ContextExploratory evidence for a novel digital adjunct to traditional mental health support in IBD, addressing known barriers to CBT access.
No standard claimed for this paper

Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.

George AT … Rubin DT · Inflammatory Bowel Diseases · IF 4.5 · PubMed ↗Permalink
← Read the whole of issue №19 Every paper GI Signals surfaces gets a page like this one. All issues